Related references
Note: Only part of the references are listed.Use of Medications to Reduce Risk for Primary Breast Cancer: A Systematic Review for the US Preventive Services Task Force
Heidi D. Nelson et al.
ANNALS OF INTERNAL MEDICINE (2013)
Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980
C. Bosetti et al.
ANNALS OF ONCOLOGY (2013)
A phase-III prevention trial of low-dose tamoxifen in postmenopausal hormone replacement therapy users: the HOT study
A. DeCensi et al.
ANNALS OF ONCOLOGY (2013)
Breast cancer incidence in postmenopausal women with osteoporosis or low bone mass using arzoxifene
Trevor J. Powles et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Metformin and Incident Breast Cancer among Diabetic Women: A Population-Based Case-Control Study in Denmark
Jaclyn Lee Fong Bosco et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Arzoxifene for Prevention of Fractures and Invasive Breast Cancer in Postmenopausal Women
Steven R. Cummings et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Projecting Individualized Absolute Invasive Breast Cancer Risk in Asian and Pacific Islander American Women
Rayna K. Matsuno et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Exemestane for Breast-Cancer Prevention in Postmenopausal Women
Paul E. Goss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing Breast Cancer
Victor G. Vogel et al.
CANCER PREVENTION RESEARCH (2010)
Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer
Michael Bodmer et al.
DIABETES CARE (2010)
Oral Bisphosphonate Use and Breast Cancer Incidence in Postmenopausal Women
Rowan T. Chlebowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Patient Decisions About Breast Cancer Chemoprevention: A Systematic Review and Meta-Analysis
Mary E. Ropka et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Use of Bisphosphonates and Risk of Postmenopausal Breast Cancer
Gad Rennert et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Breast Cancer Incidence in the Randomized PEARL Trial of Lasofoxifene in Postmenopausal Osteoporotic Women
Andrea Z. LaCroix et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Lasofoxifene in Postmenopausal Women with Osteoporosis
Steven R. Cummings et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Association between NSAIDs use and breast cancer risk: a systematic review and meta-analysis
Ya-shuang Zhao et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Modification of Ovarian Cancer Risk by BRCA1/2-interacting Genes in a Multicenter Cohort of BRCA1/2 Mutation Carriers
Timothy R. Rebbeck et al.
CANCER RESEARCH (2009)
Global trends in breast cancer incidence and mortality
Peggy L. Porter
SALUD PUBLICA DE MEXICO (2009)
The effects of tibolone in older postmenopausal women
Steven R. Cummings et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Projecting individualized absolute invasive breast cancer risk in African American women
Mitchell H. Gail et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Tamoxifen for the prevention of breast cancer: Late results of the Italian randomized tamoxifen prevention trial among women with hysterectomy
Umberto Veronesi et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Long-term results of tamoxifen prophylaxis for breast cancer-96-month follow-up of the randomized IBIS-I trial
Jack Cuzick et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Twenty-year follow-up of the royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial
Trevor J. Powles et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Statins and risk of cancer: A systematic review and metaanalysis
Danielle R. L. Browning et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women
Elizabeth Barrett-Connor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer
U. Veronesi et al.
ANNALS OF ONCOLOGY (2006)
Use of statins and breast cancer: A meta-analysis of seven randomized clinical trials and nine observational studies
S Bonovas et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Tamoxifen for the prevention of breast cancer: Current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study
B Fisher et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Neoadjuvant percutaneous 4-hydroxytamoxifen decreases breast tumoral cell proliferation: A prospective controlled randomized study comparing three doses of 4-hydroxytamoxifen gel to oral tamoxifen
P Rouanet et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Aromatase inhibitors for breast cancer prevention
J Cuzick
JOURNAL OF CLINICAL ONCOLOGY (2005)
A breast cancer prediction model incorporating familial and personal risk factors
J Tyrer et al.
STATISTICS IN MEDICINE (2004)
Continuing outcomes relevant to evista: Breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene
S Martino et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2 -: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial
MC King et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial
JA Cauley et al.
BREAST CANCER RESEARCH AND TREATMENT (2001)
Share Paper
